Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Tl‑3‑093 is an experimental small molecule dipeptide derivative with the chemical formula C25H33N3O5 and a molecular weight of approximately 455.5 g/mol. It is classified as a dipeptide, specifically N-benzoxycarbonyl-L-alanyl-L-valyl-L‑phenylalaninol (Cbz-Ala-Val-Pheol). The compound has been studied in medicinal chemistry and drug discovery, but there are no approved indications or advanced clinical trials reported for this agent. Its precise mechanism of action and therapeutic target have not been publicly disclosed[1][3][2].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Tl-3-093.